Efficacy and Safety of Dabigatran for Thromboprophylaxis after Total Knee Arthroplasty

Not Applicable

Recruiting

• Conditions: patients underwent knee replacement surgery; dabigatran, deep vein thrombosis, pulmonary embolism, new oral anticoagulant, prophylaxis, knee replacement, Asian

• Registration Number: TCTR20160208001
• Lead Sponsor: Golden Jubilee Medical Center, Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-08
• Study Completion: 2017-02-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

patients who underwent knee replacement surgery

Exclusion Criteria

allergic to dabigatran
history of previous DVT, history of abnormal bleeding within 1 year
eGFR < 50 ml/min
abnormal bleeding time

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Deep vein thrombosis 7 day after surgery Doppler ultrasonography,Major bleeding complication 7 day after surgery Clinical examination

Secondary Outcome Measures

Name	Time	Method
Minor bleeding complication 7 day after surgery Clinical examination